|
Product Details:
Payment & Shipping Terms:
|
| Purity: | 99% | Cas No.: | 1890208-58-8 |
|---|---|---|---|
| Product NamRopivacainee: | Compound 7P | Appearance: | White Powder |
| Assay: | 99% Compound 7P | Grade: | Pharmaceutical Grade |
| Storage: | Cool Dried Storage | Application: | Pharmaceutical Raw Intermediates |
| High Light: | raw materials for pharma industry,intermediates in pharmaceuticals |
||
Nootropics powder 99% Compound 7P CAS 1890208-58-8 Pharmaceutical Intermediate
Details:
Chemical Name: 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide ;2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-methoxypyridin-3-yl)acetamide
CAS No.: 1890208-58-8
Reaxys Registry Number: 29568294
Molecular Formula: C22H23N3O5S
Molecular Weight: 441.508
Assay:99%min
InChI Key: NAXWKPFXCOBXLE-UHFFFAOYSA-N
Density(Predicted): 1.329±0.06 g/cm3 |Condition:Temp:20 Press:760Torr
Function:
REPAIRING CRANIAL NERVES
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1) .
Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential, and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways .
Packing:
Nootropics powder 99% Compound 7P CAS 1890208-58-8 Pharmaceutical Intermediate
Contact Person: bruce
Tel: +8618874586545
